OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism
Sheng Zhang, Yunkai Zhang, Xuewen Duan, et al.
Circulation (2024) Vol. 149, Iss. 25, pp. 1982-2001
Open Access | Times Cited: 20

Showing 20 citing articles:

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan, Ruixuan Wang, Zhenjie Yi, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3

Glucose-Regulating Hydrogel for Immune Modulation and Angiogenesis through Metabolic Reprogramming and LARP7-SIRT1 Pathway in Infected Diabetic Wounds
Yuheng Liao, Zhenhe Zhang, Weixian Hu, et al.
Biomaterials (2025) Vol. 318, pp. 123182-123182
Closed Access | Times Cited: 1

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access

Sirtuin1 mitigates hypoxia-induced cardiomyocyte apoptosis in myocardial infarction via PHD3/HIF-1α
Yafen Chen, Shuyao Shan, Qiqi Xue, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access

Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment
Jun Ouyang, Dong-de Wu, Y. Gan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access

Targeting gut-immune-heart modulate cardiac remodeling after acute myocardial infarction
Jinmei Yu, Lin Zhou, Guo Li, et al.
Life Sciences (2025), pp. 123606-123606
Open Access

Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis
Zejuan Liu, Chen Chen, Yulin Zhang, et al.
Advanced Materials (2025)
Closed Access

Colchicine inhibits myocardial pyroptosis and reduces myocardial cell injury after myocardial infarction through the ESR1-PI3K-Akt-NF-κB signaling pathway
Qianming Chen, ShanQing Bao, Yijie Ding, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114732-114732
Closed Access

Targeting SphK1/S1PR3 axis ameliorates sepsis-induced multiple organ injury via orchestration of macrophage polarization and glycolysis
Dan Wang, Xinwen Bi, Le Zhao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1872, Iss. 1, pp. 119877-119877
Closed Access | Times Cited: 2

Potential of Epigenetic Therapy in Alleviating Cardiac Death and Fibrotic Remodeling in Myocardial Infarction
Olivier Morel
JACC Basic to Translational Science (2024) Vol. 9, Iss. 5, pp. 649-651
Open Access | Times Cited: 1

The Role of Alarmins in the Pathogenesis of Atherosclerosis and Myocardial Infarction
Kajetan Kiełbowski, Patryk Skórka, Paulina Plewa, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8995-9015
Open Access | Times Cited: 1

At the heart of inflammation: Unravelling cardiac resident macrophage biology
Yingnan Liao, Liyuan Zhu
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 17
Open Access | Times Cited: 1

Cardiac macrophages in maintaining heart homeostasis and regulating ventricular remodeling of heart diseases
Mengjie Kang, Hui Jia, Feng Mei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1

The Macrophage–Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis
Stelios Psarras
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1403-1403
Open Access | Times Cited: 1

Kidney function mediates the effects of four per-and polyfluoroalkyl substances (PFAS) on atherosclerotic cardiovascular disease
Zhengqi Wei, Keke Wei, Ming Yang, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 288, pp. 117395-117395
Closed Access | Times Cited: 1

Epigenetic modifications and emerging therapeutic targets in cardiovascular aging and diseases
Y. Qiu, Qing Xu, Peng Xie, et al.
Pharmacological Research (2024), pp. 107546-107546
Open Access | Times Cited: 1

Reprogramming macrophage metabolism following myocardial infarction: A neglected piece of a therapeutic opportunity
Bao‐Ping Xie, Jiahua Li, Yanmei Lou, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113019-113019
Closed Access

Page 1

Scroll to top